Brian C Callaghan1, Rong Xia2, Evan Reynolds3, Mousumi Banerjee4, Charles Burant5, Amy Rothberg6, Rodica Pop-Busui7, Emily Villegas-Umana8, Eva L Feldman9. 1. Department of Neurology, University of Michigan, Ann Arbor, MI, USA. Electronic address: bcallagh@med.umich.edu. 2. School of Public Health, University of Michigan, Ann Arbor, MI, USA. Electronic address: rongxia@umich.edu. 3. School of Public Health, University of Michigan, Ann Arbor, MI, USA. Electronic address: evanlr@umich.edu. 4. School of Public Health, University of Michigan, Ann Arbor, MI, USA. Electronic address: mousumib@umich.edu. 5. Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI, USA. Electronic address: burantc@med.umich.edu. 6. Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI, USA. Electronic address: arothber@med.umich.edu. 7. Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI, USA. Electronic address: rpbusui@med.umich.edu. 8. Department of Neurology, University of Michigan, Ann Arbor, MI, USA. Electronic address: ligonemi@med.umich.edu. 9. Department of Neurology, University of Michigan, Ann Arbor, MI, USA. Electronic address: efeldman@med.umich.edu.
Abstract
OBJECTIVE: To determine the comparative diagnostic characteristics of neuropathy measures in an obese population. METHODS: We recruited obese participants from the University of Michigan's Weight Management Program. Receiver operative characteristic analysis determined the area under the curve (AUC) of neuropathy measures for distal symmetric polyneuropathy (DSP), small fiber neuropathy (SFN), and cardiovascular autonomic neuropathy (CAN). The best test combinations were determined using stepwise and Score subset selection models. RESULTS: We enrolled 120 obese participants. For DSP, seven of 42 neuropathy measures (Utah Early Neuropathy Score (UENS, N = 62), Michigan Neuropathy Screening Instrument (MNSI) reduced combined index, MNSI examination, nerve fiber density (NFD) leg, tibial F response, MNSI questionnaire, peroneal distal motor latency) had AUCs ≥ 0.75. Three of 19 small fiber nerve measures for SFN (UENS, NFD leg, Sudoscan feet (N = 70)) and zero of 16 CAN measures had AUCs ≥ 0.75. Combinations of tests performed better than individual tests with AUCs of 0.82 for DSP (two parameters) and 0.84 for SFN (three parameters). CONCLUSIONS: Many neuropathy measures demonstrate good test performance for DSP in obese participants. Select few small fiber nerve measures performed well for SFN, and none for CAN. SIGNIFICANCE: Specific combinations of tests should be used for research studies to maximize diagnostic performance in obese cohorts. Published by Elsevier B.V.
OBJECTIVE: To determine the comparative diagnostic characteristics of neuropathy measures in an obese population. METHODS: We recruited obeseparticipants from the University of Michigan's Weight Management Program. Receiver operative characteristic analysis determined the area under the curve (AUC) of neuropathy measures for distal symmetric polyneuropathy (DSP), small fiber neuropathy (SFN), and cardiovascular autonomic neuropathy (CAN). The best test combinations were determined using stepwise and Score subset selection models. RESULTS: We enrolled 120 obeseparticipants. For DSP, seven of 42 neuropathy measures (Utah Early Neuropathy Score (UENS, N = 62), Michigan Neuropathy Screening Instrument (MNSI) reduced combined index, MNSI examination, nerve fiber density (NFD) leg, tibial F response, MNSI questionnaire, peroneal distal motor latency) had AUCs ≥ 0.75. Three of 19 small fiber nerve measures for SFN (UENS, NFD leg, Sudoscan feet (N = 70)) and zero of 16 CAN measures had AUCs ≥ 0.75. Combinations of tests performed better than individual tests with AUCs of 0.82 for DSP (two parameters) and 0.84 for SFN (three parameters). CONCLUSIONS: Many neuropathy measures demonstrate good test performance for DSP in obeseparticipants. Select few small fiber nerve measures performed well for SFN, and none for CAN. SIGNIFICANCE: Specific combinations of tests should be used for research studies to maximize diagnostic performance in obese cohorts. Published by Elsevier B.V.
Authors: G Lauria; S T Hsieh; O Johansson; W R Kennedy; J M Leger; S I Mellgren; M Nolano; I S J Merkies; M Polydefkis; A G Smith; C Sommer; J Valls-Solé Journal: Eur J Neurol Date: 2010-07 Impact factor: 6.089
Authors: J D England; G S Gronseth; G Franklin; R G Miller; A K Asbury; G T Carter; J A Cohen; M A Fisher; J F Howard; L J Kinsella; N Latov; R A Lewis; P A Low; A J Sumner Journal: Neurology Date: 2005-01-25 Impact factor: 9.910
Authors: K Van Acker; D Bouhassira; D De Bacquer; S Weiss; K Matthys; H Raemen; C Mathieu; I M Colin Journal: Diabetes Metab Date: 2009-03-17 Impact factor: 6.041
Authors: Rodica Pop-Busui; Andrew J M Boulton; Eva L Feldman; Vera Bril; Roy Freeman; Rayaz A Malik; Jay M Sosenko; Dan Ziegler Journal: Diabetes Care Date: 2017-01 Impact factor: 19.112
Authors: Amy E Rothberg; Laura N McEwen; Andrew T Kraftson; Nevin Ajluni; Christine E Fowler; Nicole M Miller; Katherine R Zurales; William H Herman Journal: BMC Obes Date: 2015-03-01
Authors: Maya Dannawi; Mansour E Riachi; Antony F Haddad; Mohamed El Massry; Mary Haddad; Pamela Moukarzel; Frédéric Harb; Hilda E Ghadieh; Assaad A Eid Journal: Metabol Open Date: 2022-03-13
Authors: Farsad Afshinnia; Evan L Reynolds; Thekkelnaycke M Rajendiran; Tanu Soni; Jaeman Byun; Masha G Savelieff; Helen C Looker; Robert G Nelson; George Michailidis; Brian C Callaghan; Subramaniam Pennathur; Eva L Feldman Journal: Ann Clin Transl Neurol Date: 2022-08-03 Impact factor: 5.430
Authors: Evan L Reynolds; Brian C Callaghan; Mousumi Banerjee; Eva L Feldman; Vijay Viswanathan Journal: J Diabetes Complications Date: 2020-06-11 Impact factor: 2.852
Authors: Brian C Callaghan; Evan Reynolds; Mousumi Banerjee; Ericka Chant; Emily Villegas-Umana; Eva L Feldman Journal: Mayo Clin Proc Date: 2020-07 Impact factor: 7.616
Authors: Evan L Reynolds; Gulcin Akinci; Mousumi Banerjee; Helen C Looker; Adam Patterson; Robert G Nelson; Eva L Feldman; Brian C Callaghan Journal: JCI Insight Date: 2021-05-24